Pathogenesis of lung cancer signalling pathways: roadmap for therapies

Brambilla E., Gazdar A.

Source: Eur Respir J 2009; 33: 1485-1497
Journal Issue: June
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Brambilla E., Gazdar A.. Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J 2009; 33: 1485-1497

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006



Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005

Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002



High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009



New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

The biology of lung cancer
Source: Eur Respir Mon; 2009: 44: 88–105
Year: 2009

INTS12 knockdown leads to perturbation of genes and pathways of relevance to airway biology
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015


The role of molecular pathology in diagnosis and treatment of lung cancer
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007



New outlook on the Th1/Th2-alternative signaling pathways in asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010



Delivery of siRNA to the lungs and airways
Source: Annual Congress 2005 - Selective gene knockout - the use of small interference RNA
Year: 2005

Latest treatable molecular alterations in lung cancer
Source: International Congress 2017 – A novel approach to lung cancer
Year: 2017


New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Targeting the mTOR signaling pathway to inhibit lung cell senescence in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



The biology of lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=61
Year: 2001

Pathogenesis, molecular and cellular features
Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management
Year: 2006

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009